Pain and Inflammation Research
Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.
Pain and Inflammation Research Products Areas
Products for Pain and Inflammation Research - Page 42
- Cat.No. Product Name Information/Activity
-
BCC3942
Cilengitide
Cilengitide, a cyclic RGD-containing peptide, is a potent and selective integrin inhibitor for αvβ3 and αvβ5 receptor, with IC50s of 4 and 79 nM, respectively.
-
BCC5988
Echistatin, α1 isoform
154303-05-6
-
BCC6998
GR 144053 trihydrochloride
1215333-48-4
-
BCC5938
KF 38789
257292-29-8
-
BCC6229
LDV FITC
1207610-07-8
-
BCC6332
Leukadherin 1
Leukadherin-1 is a specific agonist of complement receptor 3 (CR3) and the leukocyte surface αMβ2 integrin CD11b/CD18.
-
BCC3943
MNS
MNS is a potent and selective inhibitor of Src and Syk tyrosine kinases.
-
BCC7458
OGT 2115
OGT 2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT 2115 has anti-angiogenic properties (IC50 of 1 μM). OGT 2115 also inhibits heparan sulfate degradation activity.
-
BCC6275
P11
848644-86-0
-
BCC6105
PM 102
1234564-95-4


